![Encephalopathy associated with metoclopramide use in a patient with Parkinson's disease. | Semantic Scholar Encephalopathy associated with metoclopramide use in a patient with Parkinson's disease. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1c6496e9385cb77f416adbf923e16f63b3a6c352/3-Table1-1.png)
Encephalopathy associated with metoclopramide use in a patient with Parkinson's disease. | Semantic Scholar
![Non-oral dopaminergic therapies for Parkinson's disease: current treatments and the future | npj Parkinson's Disease Non-oral dopaminergic therapies for Parkinson's disease: current treatments and the future | npj Parkinson's Disease](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnpjparkd.2016.23/MediaObjects/41531_2016_Article_BFnpjparkd201623_Fig1_HTML.jpg)
Non-oral dopaminergic therapies for Parkinson's disease: current treatments and the future | npj Parkinson's Disease
1 MEDICATION ADMINISTRATION IN THE MANAGEMENT OF PARKINSON DISEASE A Position Paper Prepared by the Michigan Parkinson Foundati
![Medication management of patients with enteral feeding tubes | Working party guideline/algorithm | Guidelines Medication management of patients with enteral feeding tubes | Working party guideline/algorithm | Guidelines](https://d3j7puhwqgd8ts.cloudfront.net/Pictures/1024x536/0/2/1/5021_algorithmforadministrationofdrugsviaenteralfeedingtubes_827148.png)
Medication management of patients with enteral feeding tubes | Working party guideline/algorithm | Guidelines
![Improvement of Medical Management of Parkinson's Disease in Inpatients Tom Stoker MA (hons.) MB B.chir MRCP(UK) Learning To Make a Difference. - ppt download Improvement of Medical Management of Parkinson's Disease in Inpatients Tom Stoker MA (hons.) MB B.chir MRCP(UK) Learning To Make a Difference. - ppt download](https://images.slideplayer.com/21/6271661/slides/slide_5.jpg)
Improvement of Medical Management of Parkinson's Disease in Inpatients Tom Stoker MA (hons.) MB B.chir MRCP(UK) Learning To Make a Difference. - ppt download
![Co-evolution of machine learning and digital technologies to improve monitoring of Parkinson's disease motor symptoms | npj Digital Medicine Co-evolution of machine learning and digital technologies to improve monitoring of Parkinson's disease motor symptoms | npj Digital Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41746-022-00568-y/MediaObjects/41746_2022_568_Fig1_HTML.png)
Co-evolution of machine learning and digital technologies to improve monitoring of Parkinson's disease motor symptoms | npj Digital Medicine
![SciELO - Saúde Pública - Use of cuban recombinant human erythropoietin in Parkinson's disease treatment Use of cuban recombinant human erythropoietin in Parkinson's disease treatment SciELO - Saúde Pública - Use of cuban recombinant human erythropoietin in Parkinson's disease treatment Use of cuban recombinant human erythropoietin in Parkinson's disease treatment](https://www.scielosp.org/media/assets/medicc/v14n1/03t01.jpg)
SciELO - Saúde Pública - Use of cuban recombinant human erythropoietin in Parkinson's disease treatment Use of cuban recombinant human erythropoietin in Parkinson's disease treatment
![Hospital Improves On-Time Administration of Medication to Parkinson Patients | Journal of Parkinson's Disease Hospital Improves On-Time Administration of Medication to Parkinson Patients | Journal of Parkinson's Disease](https://www.iospress.nl/wp-content/uploads/2020/07/JPD10-4_PR1_image.jpg)
Hospital Improves On-Time Administration of Medication to Parkinson Patients | Journal of Parkinson's Disease
![Initiation of pharmacological therapy in Parkinson's disease: when, why, and how - The Lancet Neurology Initiation of pharmacological therapy in Parkinson's disease: when, why, and how - The Lancet Neurology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/7692ab80-aab1-465c-9726-ab6233874655/gr1_lrg.jpg)
Initiation of pharmacological therapy in Parkinson's disease: when, why, and how - The Lancet Neurology
![The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease - ScienceDirect The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1550413122000456-fx1.jpg)
The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease - ScienceDirect
![Algorithms for the treatment of motor problems in Parkinson's disease - Dietrichs - 2017 - Acta Neurologica Scandinavica - Wiley Online Library Algorithms for the treatment of motor problems in Parkinson's disease - Dietrichs - 2017 - Acta Neurologica Scandinavica - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/4b65f3f6-68fc-4430-a0c2-6d6d5b1dbaee/ane12733-fig-0001-m.jpg)
Algorithms for the treatment of motor problems in Parkinson's disease - Dietrichs - 2017 - Acta Neurologica Scandinavica - Wiley Online Library
![Current and experimental treatments of Parkinson disease: A guide for neuroscientists - Oertel - 2016 - Journal of Neurochemistry - Wiley Online Library Current and experimental treatments of Parkinson disease: A guide for neuroscientists - Oertel - 2016 - Journal of Neurochemistry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/cea7a0d1-4b84-4ff0-a629-d934ddbf83b5/jnc13750-fig-0002-m.jpg)